Get started
Author

Paula Abola

ORCID: 0009-0008-1936-5559
Observed ORCID: 0009-0008-1936-5559
OpenAlex ID: A5095934116
Influence of Sociodemographic Variables on Patient and Practitioner Knowledge of Pharmacological Management Options for Parkinson's Disease
2025 · Paula Abola, Kristin Lefebvre, et al. · American Journal of Medical and Clinical Research & Reviews · 2
PDF
Predictors of Student Disengagement in Fully Online Higher Education Programs
2026 · Paula Abola · PUPIL International Journal of Teaching Education and Learning · 1
PDF
Disparities in neurological management for Parkinson’s disease in Latvia: Pilot study evidence
2026 · Paula Abola, Mitchell Wolden · Equity Neuroscience · 1
Influence of sociodemographic variables on patient and practitioner knowledge of non-pharmacological management options for Parkinson's disease
2025 · Paula Abola, Benjamin Wolden, et al. · Exercise and Quality of Life · 1
Incidence of Adverse Events in Individuals With Parkinson's Disease Treated With Monoamine Oxidase-B Inhibitor Safinamide as an Add-On to Levodopa Treatment: A Systematic Review and Meta-Analysis
2024 · Paula Abola, Niraj Adhikari · Neurology and Neuroscience · 1
PDF
Liquid Subcutaneous Levodopa-Carbidopa ND0612 Effects on Motor Symptoms in Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis
2024 · Paula Abola, Mitchell Wolden, et al. · Advances in Parkinson s Disease · 1
Perceived AI literacy and learning-related outcomes among higher education students using generative AI
2026 · Paula Abola · Journal of Learning Development in Higher Education
PDF
The Urgent Need for a Parkinson’s Disease Patient Support Group in Latvia
2026 · Paula Abola · EMJ Neurology
PDF
Patient health literacy as a critical missing component in the PLAN to address the Parkinson pandemic
2026 · Paula Abola, Benjamin Wolden, et al. · Journal of Parkinson s Disease
Parkinson's Disease Care in Latvia: Insights from Patients and Neurologists
2026 · Paula Abola · EIU Journal of Action Research
Exploring perceptions and predictors of shared decision-making in the pharmacological management of Parkinson’s disease: insights from patients and healthcare providers
2026 · Paula Abola, Benjamin Wolden, et al. · Drugs & Therapy Perspectives
PDF
Regional features in the treatment of Parkinson’s disease in the Baltic States compared to Germany
2026 · Paula Abola, Ligita Smeltere, et al. · BMC Health Services Research
Predictors of Student Disengagement in Fully Online Higher Education Programs
2026 · Paula Abola · PUPIL International Journal of Teaching Education and Learning
PDF
Predictors of Student Disengagement in Fully Online Higher Education Programs
2026 · Paula Abola
PDF
Infectious Diseases as a Potential Risk Factor for Parkinson’s Disease and Parkinsonism: A Scoping Review
2025 · Paula Abola, Dita Cerina
PDF
Subcutaneous Apomorphine infusion effects on OFF time and motor symptoms in individuals with Parkinson's disease: A systematic review and meta-analysis
2025 · Paula Abola, Benjamin Wolden, et al. · Journal of the Neurological Sciences
Incidence of Adverse and Safety Events in Individuals with Parkinson’s Disease Treated with Catechol-O-Methyltransferase Inhibitor Opicapone as an Add-On to Levodopa Treatment: A Systematic Review and Meta-Analysis
2025 · Paula Abola, George Jabishvili · Prospects in Pharmaceutical Sciences
PDF
Improving PIN Entry Accessibility for SMART-ID Users with Parkinson’s Disease.
2025 · Paula Abola
PDF
Subcutaneous Apomorphine Infusion Effects on OFF Time and Motor Symptoms in Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis
2025 · Paula Abola
PDF
Technological Advancements in the Detection and Quantification of Parkinsonian Tremor: A Scoping Review
2025 · Paula Abola, Kristin Lefebvre · Topics in Geriatric Rehabilitation
Technological Advancements in the Reduction of Parkinsonian Tremor: A Scoping Review
2025 · Paula Abola, Kristin Lefebvre · Topics in Geriatric Rehabilitation
Intra-individual Variations in Voice Variables Among Individuals With and Without Parkinson’s Disease
2025 · Paula Abola, Mitchell Wolden · Cureus
Monoamine Oxidase-B Inhibitor Rasagiline Effects on Motor and Non-Motor Symptoms in Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis
2024 · Paula Abola, Mitchell Wolden · Advances in Parkinson s Disease
PDF
Works count: 24
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type